Qureshi Zaheer A, Ghazanfar Haider, Altaf Faryal, Ghazanfar Ali, Hasan Khushbu Z, Kandhi Sameer, Fortuzi Ked, Dileep Arundhati, Shrivastava Shitij
Medicine, Frank H. Netter MD School of Medicine, Quinnipiac University, Bridgeport, USA.
Internal Medicine, BronxCare Health System, New York City, USA.
Cureus. 2024 Mar 4;16(3):e55498. doi: 10.7759/cureus.55498. eCollection 2024 Mar.
Cryptococcosis is a fungal infectious disease that enormously impacts human health worldwide. Cryptococcal meningitis is the most severe disease caused by the fungus Cryptococcus, and can lead to death, if left untreated. Many patients develop resistance and progress to death even after treatment. It requires a prolonged treatment course in people with AIDS. This narrative review provides an evidence-based summary of the current treatment modalities and future trial options, including newer ones, namely, 18B7, T-2307, VT-1598, AR12, manogepix, and miltefosine. This review also evaluated the management and empiric treatment of cryptococcus meningitis. The disease can easily evade diagnosis with subacute presentation. Despite the severity of the disease, treatment options for cryptococcosis remain limited, and more research is needed.
隐球菌病是一种在全球范围内对人类健康产生巨大影响的真菌性传染病。隐球菌性脑膜炎是由新型隐球菌引起的最严重疾病,若不治疗可导致死亡。许多患者即使在接受治疗后仍会产生耐药性并最终死亡。艾滋病患者需要长期治疗。本叙述性综述基于证据总结了当前的治疗方式以及未来的试验选择,包括较新的药物,即18B7、T - 2307、VT - 1598、AR12、马尼地平(manogepix)和米替福新。本综述还评估了隐球菌性脑膜炎的管理和经验性治疗。该疾病以亚急性表现时很容易漏诊。尽管病情严重,但隐球菌病的治疗选择仍然有限,仍需要更多的研究。